HK Stock MarketDetailed Quotes

ESSEX BIO-TECH (01061)

Watchlist
  • 3.360
  • +0.030+0.90%
Trading Apr 15 14:24 CST
1.91BMarket Cap5.99P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ESSEX BIO-TECH (01061) Revenue Breakdown Overview

By Business/Source

No Data

By Product

Currency:HKD
2025/FY
Stock NameRevenueRatio
Surgery895.9M49.39%
Ophthalmology835.03M46.04%
医疗保健及伙伴服务82.87M4.57%

By Country/Region

Currency:HKD
2025/FY
Stock NameRevenueRatio
China1.8B99.41%
Overseas10.7M0.59%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -0.56%
Sample Name
Sample Code
 -5.37%
Sample Name
Sample Code
 -6.20%
4
SHANGHAI PECHEM
00338
-9.86%
5
CNOOC
00883
-11.49%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +23.27%
Sample Name
Sample Code
 +21.59%
Sample Name
Sample Code
 +16.20%
4
Hangzhou Shunwang Technology
300113
+12.02%
5
Ucloud Technology Co., Ltd
688158
+9.55%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -